Malignant minor pleural effusion detected on thoracotomy for patients with non–small cell lung cancer: is tumor resection beneficial for prognosis? Noriyoshi.

Slides:

Advertisements

Similar presentations

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Advertisements

Surgical Intervention for Non–Small-Cell Lung Cancer Patients with Pleural Carcinomatosis: Results From the Japanese Lung Cancer Registry in 2004 Tomohiko.

Thomas J. Birdas, MD, Richard P. M

Cytologically malignant margins of wedge resected stage I non-small cell lung cancer Noriyoshi Sawabata, MD, Akihide Matsumura, MD, Mitsunori Ohota, MD,

E-cadherin expression associated with differentiation and prognosis in patients with non–small cell lung cancer Dage Liu, MD, Cheng-long Huang, MD, Kotaro.

Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences Jean Deslauriers, MD, Jocelyn Grégoire,

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection Morihito Okada,

Quality of life after tailored combined surgery for stage I non–small-cell lung cancer and severe emphysema Eugenio Pompeo, MD, Enrico De Dominicis,

Short- and Long-Term Outcomes after Large Pulmonary Resection for Germ Cell Tumors After Bleomycin-Combination Chemotherapy Rafael S. Andrade, MD, Kenneth.

Clinicopathological and biological assessment of lung cancers with pleural dissemination Yasuhiko Ohta, MD, Yoko Tanaka, PhD, Takuo Hara, MD, Makoto.

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.

Solitary Fibrous Tumors of the Pleura: Surgical Outcome and Clinical Course Sook Hwan Sung, MD, Jee-Won Chang, MD, Jhingook Kim, MD, Kyung Soo Lee, MD,

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,

Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer Akihito Watanabe, MD, Masao Hosokawa, MD,

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Ki-67 expression and prognosis for smokers with resected stage i Non–Small cell lung cancer Yukiko Haga, MD, Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi.

Penetration of intravenous antibiotics from the lung into the pleural space after pulmonary resection* T. Sakuma, MD, H. Kubo, MD, T. Tanita, MD, K.

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Ongoing prospective study of segmentectomy for small lung tumors

Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy Morihito Okada, MD, Hiroyuki Yamagishi,

Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion Kenji Suzuki, MD, Hisao.

Sex-associated differences in survival of patients undergoing resection for lung cancer Mark K Ferguson, MD, Jun Wang, MD, Philip C Hoffman, MD, Daniel.

Surgical treatment of non-small cell lung cancer 1 cm or less in diameter Daniel L Miller, MD, Charles M Rowland, MS, Claude Deschamps, MD, Mark S Allen,

Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer Usman Ahmad, MD, Traves D. Crabtree,

Lung Cancer Surgery in Patients With Liver Cirrhosis

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Thomas J. Birdas, MD, Richard P. M

Prognostic factors in clinical stage I non–small cell lung cancer

Visceral pleural involvement in nonsmall cell lung cancer: prognostic significance Toshihiro Osaki, MD, PhD, Akira Nagashima, MD, PhD, Takashi Yoshimatsu,

Use of Amiodarone After Major Lung Resection

Does Repeated Lung Resection Provide Long-Term Survival for Recurrent Pulmonary Metastases of Colorectal Cancer? Results of a Retrospective Japanese Multicenter.

Clinical Significance of Tumor-Infiltrating Lymphocytes in Lung Neoplasms Enrico Ruffini, MD, Sofia Asioli, MD, Pier Luigi Filosso, MD, Paraskevas Lyberis,

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Results of surgical intervention for p-stage IIIA (N2) non–small cell lung cancer: Acceptable prognosis predicted by complete resection in patients with.

Prognostic assessment of 1310 patients with non–small-cell lung cancer who underwent complete resection from 1980 to 1993 Kunihiko Inoue, MDa, Masami.

Performance Status and Smoking Status Are Independent Favorable Prognostic Factors for Survival in Non-small Cell Lung Cancer: A Comprehensive Analysis.

Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD

Favorable results after sleeve lobectomy or bronchoplasty for bronchial malignancies Hon-Chi Suen, MBBS, Bryan F Meyers, MD, Tracey Guthrie, BSN, Mary.

Pulmonary Resection for Lung Cancer in Octogenarians

Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung Marc Riquet, MD, Dominique Manac’h, MD, Françoise Le.

Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD,

Subcategorization of Resectable Non-Small Cell Lung Cancer Involving Neighboring Structures Noriaki Sakakura, MD, Shoichi Mori, MD, Futoshi Ishiguro,

Lewis Y antigen expression and postoperative survival in non–small cell lung cancer Fumihiro Tanaka, MD, Ryo Miyahara, MD, Yohsuke Ohtake, MD, Kazuhiro.

Resection of adrenal metastases from non-small cell lung cancer: a multicenter study Henri Porte, MD, PhD, Joëlle Siat, MD, Benoit Guibert, MD, Francoise.

Is there a role for pneumonectomy in pulmonary metastases?1

Repair of Thoracoabdominal Aortic Aneurysms in Octogenarians

Problems related to TNM staging: Patients with stage III non–small cell lung cancer Kotaro Kameyama, MD, Cheng-long Huang, MD, Dage Liu, MD, Taku Okamoto,

James D Luketich, Michael E Burt The Annals of Thoracic Surgery

Beware the malignant jellyfish

Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study Noriyoshi Sawabata, MD, Mitsunori.

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Neal S Goldstein, MD The Annals of Thoracic Surgery

Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer Steven M Keller, MD, Sudeshna Adak,

Nonanatomic prognostic factors in resected nonsmall cell lung carcinoma: the importance of perineural invasion as a new prognostic marker Adnan Sayar,

A Propensity-Matched Comparison of Pleurodesis or Tunneled Pleural Catheter in Patients Undergoing Diagnostic Thoracoscopy for Malignancy Richard K.

Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter Joe B Putnam, MD, Garrett L Walsh, MD, Stephen G Swisher,

Salvage surgery for advanced non–small cell lung cancer after response to gefitinib Tomoyuki Hishida, MD, Kanji Nagai, MD, Tetsuya Mitsudomi, MD, Kohei.

Who should decide margin length in pulmonary excision of lung cancer?

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found?

Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma Joachim Pfannschmidt, MD, Hans Hoffmann, MD, PhD, Thomas.

Visceral Pleural Invasion Classification in Non–Small-Cell Lung Cancer in the 7th Edition of the Tumor, Node, Metastasis Classification for Lung Cancer:

Surgical Resection of Pulmonary Malignant Tumors After Living Donor Liver Transplantation Fumihiro Shoji, MD, Daigo Kawano, MD, Toru Ikegami, MD, Yuji.

Surgery for pulmonary metastases from colorectal carcinoma

Presentation transcript:

Malignant minor pleural effusion detected on thoracotomy for patients with non–small cell lung cancer: is tumor resection beneficial for prognosis? Noriyoshi Sawabata, MD, Akihide Matsumura, MD, Akira Motohiro, MD, Yoshihiko Osaka, MD, Keiichiro Gennga, MD, Shimao Fukai, MD, Takashi Mori, MD The Annals of Thoracic Surgery Volume 73, Issue 2, Pages 412-415 (February 2002) DOI: 10.1016/S0003-4975(01)03426-9

Fig 1 Survival curve for the 43 patients with malignant minor pleural effusion. Median survival time is 13 months and 5-year survival rate is 5%. The Annals of Thoracic Surgery 2002 73, 412-415DOI: (10.1016/S0003-4975(01)03426-9)

Fig 2 Group C patients (ie, patients who underwent grossly complete resection) achieved a median survival time of 13 months and a 5-year survival rate of 9%; group I (patients who underwent incomplete resection) had a median survival time of 34 months and a 5-year survival rate of 10% (p = 0.3); and group E (patients who underwent exploratory thoracotomy) had a median survival time of 17 months and a 5-year survival rate of 0% (p = 0.8). Values were calculated on the basis of a comparison between group C and each of the other groups. The Annals of Thoracic Surgery 2002 73, 412-415DOI: (10.1016/S0003-4975(01)03426-9)